← Back to Search

Behavioural Intervention

MedBIKE for Hypoplastic Left Heart Syndrome (MedBike Trial)

N/A
Waitlist Available
Led By Nee Khoo, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
single ventricle patients with Fontan circulation
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre- vo2 max performed 1 week before 24 hiit exercise sessions and within 1 week after last session
Awards & highlights

MedBike Trial Summary

This trial will test if a new rehabilitation program using technology can help people with a certain heart condition.

Eligible Conditions
  • Hypoplastic Left Heart Syndrome
  • Congenital Heart Defects
  • Physical Activity

MedBike Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MedBike Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre- vo2 max performed 1 week before 24 hiit exercise sessions and within 1 week after last session
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre- vo2 max performed 1 week before 24 hiit exercise sessions and within 1 week after last session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Exercise capacity
Secondary outcome measures
Number of participants with exercise program specific adverse events
Qualitative interviews to determine the perception of exercise in CHD patient

MedBike Trial Design

1Treatment groups
Experimental Treatment
Group I: HIIT Exercise ProgramExperimental Treatment1 Intervention
Exercise on a MedBIKE 3 times a week for 8 weeks with pre- and post-CPET testing, questionnaires and qualitative interviews.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MedBIKE
2019
N/A
~20

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
884 Previous Clinical Trials
393,225 Total Patients Enrolled
2 Trials studying Hypoplastic Left Heart Syndrome
22 Patients Enrolled for Hypoplastic Left Heart Syndrome
Nee Khoo, MDPrincipal InvestigatorUniversity of Alberta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Mar 2025